Protecting investments in polio eradication: the past, present and future of surveillance for acute flaccid paralysis.

DLHeymann; EMDe Gourville; RBAylward; (2004) Protecting investments in polio eradication: the past, present and future of surveillance for acute flaccid paralysis. Epidemiology and infection, 132 (5). pp. 779-780. ISSN 0950-2688 DOI: 10.1017/s0950268804002638
Copy

<jats:p>In September 2003 a WHO consultation group on vaccine-derived polioviruses (VDPV) concluded that in order to prevent future generations of paralytic polio after interruption of transmission of wild poliovirus, the use of trivalent oral polio vaccine (OPV) must be stopped [1]. Another important global policy decision along the road to polio eradication thus became possible – cessation of OPV use at some time after eradication. The question now is not whether OPV must be stopped, but rather when.</jats:p>
Item Type Article
ISI 224400800001

Atom BibTeX OpenURL ContextObject in Span Multiline CSV OpenURL ContextObject Dublin Core Dublin Core MPEG-21 DIDL EndNote HTML Citation JSON MARC (ASCII) MARC (ISO 2709) METS MODS RDF+N3 RDF+N-Triples RDF+XML RIOXX2 XML Reference Manager Refer Simple Metadata ASCII Citation EP3 XML
Export

Downloads

picture_as_pdf
EI2.pdf
subject
Published Version
copyright
Available under Copyright the publishers
View Download

Explore Further

Read more research from the creator(s):

Find work associated with the faculties and division(s):

Find work from this publication:

Find other related resources: